학술논문

Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancer
Document Type
Journal
Source
INVESTIGATIONAL NEW DRUGS; SEP 11 2020, 9p.
Subject
Language
English
ISSN
15730646